Oral microbial dysbiosis and its performance in predicting oral cancer.
Adult
Aged
Cohort Studies
DNA, Bacterial
/ isolation & purification
Disease Progression
Dysbiosis
/ diagnosis
Early Detection of Cancer
/ methods
Fusobacterium nucleatum
/ genetics
Humans
Male
Microbiota
/ immunology
Middle Aged
Mouth Mucosa
/ immunology
Mouth Neoplasms
/ diagnosis
Prognosis
RNA, Ribosomal, 16S
/ genetics
Squamous Cell Carcinoma of Head and Neck
/ diagnosis
Streptococcus pneumoniae
/ genetics
Tumor Microenvironment
/ immunology
Journal
Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055
Informations de publication
Date de publication:
11 02 2021
11 02 2021
Historique:
received:
07
05
2020
revised:
10
06
2020
accepted:
16
06
2020
pubmed:
6
7
2020
medline:
29
6
2021
entrez:
5
7
2020
Statut:
ppublish
Résumé
Dysbiosis of oral microbiome may dictate the progression of oral squamous cell carcinoma (OSCC). Yet, the composition of oral microbiome fluctuates by saliva and distinct sites of oral cavity and is affected by risky behaviors (smoking, drinking and betel quid chewing) and individuals' oral health condition. To characterize the disturbances in the oral microbial population mainly due to oral tumorigenicity, we profiled the bacteria within the surface of OSCC lesion and its contralateral normal tissue from discovery (n = 74) and validation (n = 42) cohorts of male patients with cancers of the buccal mucosa. Significant alterations in the bacterial diversity and relative abundance of specific oral microbiota (most profoundly, an enrichment for genus Fusobacterium and the loss of genus Streptococcus in the tumor sites) were identified. Functional prediction of oral microbiome shown that microbial genes related to the metabolism of terpenoids and polyketides were differentially enriched between the control and tumor groups, indicating a functional role of oral microbiome in formulating a tumor microenvironment via attenuated biosynthesis of secondary metabolites with anti-cancer effects. Furthermore, the vast majority of microbial signatures detected in the discovery cohort was generalized well to the independent validation cohort, and the clinical validity of these OSCC-associated microbes was observed and successfully replicated. Overall, our analyses reveal signatures (a profusion of Fusobacterium nucleatum CTI-2 and a decrease in Streptococcus pneumoniae) and functions (decreased production of tumor-suppressive metabolites) of oral microbiota related to oral cancer.
Identifiants
pubmed: 32621740
pii: 5867492
doi: 10.1093/carcin/bgaa062
doi:
Substances chimiques
DNA, Bacterial
0
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-135Informations de copyright
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.